These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 18615483

  • 1. T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling.
    Weerasinghe P, Li Y, Guan Y, Zhang R, Tweardy DJ, Jing N.
    Prostate; 2008 Sep 15; 68(13):1430-42. PubMed ID: 18615483
    [Abstract] [Full Text] [Related]

  • 2. Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy.
    Reddy KR, Guan Y, Qin G, Zhou Z, Jing N.
    Prostate; 2011 Dec 15; 71(16):1796-809. PubMed ID: 21480310
    [Abstract] [Full Text] [Related]

  • 3. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.
    Jing N, Li Y, Xiong W, Sha W, Jing L, Tweardy DJ.
    Cancer Res; 2004 Sep 15; 64(18):6603-9. PubMed ID: 15374974
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N.
    Int J Oncol; 2007 Jul 15; 31(1):129-36. PubMed ID: 17549413
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X, Zhang J, Wang L, Wei H, Tian Z.
    BMC Cancer; 2007 Aug 04; 7():149. PubMed ID: 17683579
    [Abstract] [Full Text] [Related]

  • 10. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.
    Hu H, Lee HJ, Jiang C, Zhang J, Wang L, Zhao Y, Xiang Q, Lee EO, Kim SH, Lü J.
    Mol Cancer Ther; 2008 Sep 04; 7(9):2681-91. PubMed ID: 18790750
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
    Han Z, Wang X, Ma L, Chen L, Xiao M, Huang L, Cao Y, Bai J, Ma D, Zhou J, Hong Z.
    Oncotarget; 2014 Sep 30; 5(18):8416-28. PubMed ID: 25261365
    [Abstract] [Full Text] [Related]

  • 12. EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB.
    Civenni G, Longoni N, Costales P, Dallavalle C, García Inclán C, Albino D, Nuñez LE, Morís F, Carbone GM, Catapano CV.
    Mol Cancer Ther; 2016 May 30; 15(5):806-18. PubMed ID: 26826115
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
    Chen J, Wang J, Lin L, He L, Wu Y, Zhang L, Yi Z, Chen Y, Pang X, Liu M.
    Mol Cancer Ther; 2012 Feb 30; 11(2):277-87. PubMed ID: 22203730
    [Abstract] [Full Text] [Related]

  • 14. Enhancing or eliminating signals for cell survival to treat disease.
    Tweardy DJ, Jing N.
    Trans Am Clin Climatol Assoc; 2006 Feb 30; 117():33-51; discussion 51-2. PubMed ID: 18528463
    [Abstract] [Full Text] [Related]

  • 15. PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway.
    Zhang D, He D, Xue Y, Wang R, Wu K, Xie H, Zeng J, Wang X, Zhau HE, Chung LW, Chang LS, Li L.
    Cancer Res; 2011 Mar 15; 71(6):2193-202. PubMed ID: 21385902
    [Abstract] [Full Text] [Related]

  • 16. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT, Abdelrahim M, Connelly SF, Lee CM, Madero-Visbal R, Colon J, Smith J, Safe S, Maliakal P, Basha R.
    Prostate; 2012 Nov 15; 72(15):1648-58. PubMed ID: 22473873
    [Abstract] [Full Text] [Related]

  • 17. Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.
    Wu JC, Wang CT, Hung HC, Wu WJ, Wu DC, Chang MC, Sung PJ, Chou YW, Wen ZH, Tai MH.
    Prostate; 2016 Dec 15; 76(16):1469-1483. PubMed ID: 27416770
    [Abstract] [Full Text] [Related]

  • 18. Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model.
    Zhang J, Ahn KS, Kim C, Shanmugam MK, Siveen KS, Arfuso F, Samym RP, Deivasigamanim A, Lim LH, Wang L, Goh BC, Kumar AP, Hui KM, Sethi G.
    Antioxid Redox Signal; 2016 Apr 10; 24(11):575-89. PubMed ID: 26649526
    [Abstract] [Full Text] [Related]

  • 19. Supercritical Fluid Extraction of Citrus iyo Hort. ex Tanaka Pericarp Inhibits Growth and Induces Apoptosis Through Abrogation of STAT3 Regulated Gene Products in Human Prostate Cancer Xenograft Mouse Model.
    Kim C, Lee IH, Hyun HB, Kim JC, Gyawali R, Lee SG, Lee J, Kim SH, Shim BS, Cho SK, Ahn KS.
    Integr Cancer Ther; 2017 Jun 10; 16(2):227-243. PubMed ID: 27185319
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.
    Krishnan B, Torti FM, Gallagher PE, Tallant EA.
    Prostate; 2013 Jan 10; 73(1):60-70. PubMed ID: 22644934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.